<?xml version="1.0" encoding="UTF-8"?>
<ref id="B88-antibiotics-10-00092">
 <label>88.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Horswill</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Bali</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Shaaban</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Keily</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Jeevaratnam</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Babbs</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Reynet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wong Kai In</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats</article-title>
  <source>Br. J. Pharmacol.</source>
  <year>2009</year>
  <volume>152</volume>
  <fpage>805</fpage>
  <lpage>814</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.bjp.0707347</pub-id>
  <?supplied-pmid 17592509?>
  <pub-id pub-id-type="pmid">17592509</pub-id>
 </element-citation>
</ref>
